Postmarketing Spontaneous Pharmacovigilance Reporting Systems

Gerald J. Dal Pan, Marie Lindquist, Kate Gelperin

Research output: Chapter in Book/Report/Conference proceedingChapter

Abstract

Only 50 years ago the thalidomide tragedy served as a wake-up call to clinicians and health authorities worldwide and showed the need for effective systems to detect and seek to prevent such unforeseen consequences of therapeutic drug use. Today, increasingly sophisticated methods are employed in this effort, often referred to as pharmacovigilance. Much more needs to be done. Individuals are encouraged to report suspected adverse drug reactions or adverse events to health authorities or drug manufacturers for compilation, analysis, and effective action. This chapter describes some basic features of pharmacovigilance systems around the world.

Original languageEnglish (US)
Title of host publicationPharmacoepidemiology, Fifth Edition
PublisherWiley-Blackwell
Pages135-157
Number of pages23
ISBN (Print)0470654759, 9780470654750
DOIs
StatePublished - Jan 3 2012
Externally publishedYes

Fingerprint

Pharmacovigilance
Thalidomide
Therapeutic Uses
Drug-Related Side Effects and Adverse Reactions
Pharmaceutical Preparations
Health
Global Health

Keywords

  • Case report
  • Case series
  • Data mining
  • Database
  • Pharmacovigilance
  • Postmarketing drug safety
  • Reporting ratio
  • Signal detection
  • Spontaneous report
  • Surveillance

ASJC Scopus subject areas

  • Medicine(all)
  • Pharmacology, Toxicology and Pharmaceutics(all)

Cite this

Dal Pan, G. J., Lindquist, M., & Gelperin, K. (2012). Postmarketing Spontaneous Pharmacovigilance Reporting Systems. In Pharmacoepidemiology, Fifth Edition (pp. 135-157). Wiley-Blackwell. https://doi.org/10.1002/9781119959946.ch10

Postmarketing Spontaneous Pharmacovigilance Reporting Systems. / Dal Pan, Gerald J.; Lindquist, Marie; Gelperin, Kate.

Pharmacoepidemiology, Fifth Edition. Wiley-Blackwell, 2012. p. 135-157.

Research output: Chapter in Book/Report/Conference proceedingChapter

Dal Pan, GJ, Lindquist, M & Gelperin, K 2012, Postmarketing Spontaneous Pharmacovigilance Reporting Systems. in Pharmacoepidemiology, Fifth Edition. Wiley-Blackwell, pp. 135-157. https://doi.org/10.1002/9781119959946.ch10
Dal Pan GJ, Lindquist M, Gelperin K. Postmarketing Spontaneous Pharmacovigilance Reporting Systems. In Pharmacoepidemiology, Fifth Edition. Wiley-Blackwell. 2012. p. 135-157 https://doi.org/10.1002/9781119959946.ch10
Dal Pan, Gerald J. ; Lindquist, Marie ; Gelperin, Kate. / Postmarketing Spontaneous Pharmacovigilance Reporting Systems. Pharmacoepidemiology, Fifth Edition. Wiley-Blackwell, 2012. pp. 135-157
@inbook{82529c220ff94806a4388e0a0d9aeb32,
title = "Postmarketing Spontaneous Pharmacovigilance Reporting Systems",
abstract = "Only 50 years ago the thalidomide tragedy served as a wake-up call to clinicians and health authorities worldwide and showed the need for effective systems to detect and seek to prevent such unforeseen consequences of therapeutic drug use. Today, increasingly sophisticated methods are employed in this effort, often referred to as pharmacovigilance. Much more needs to be done. Individuals are encouraged to report suspected adverse drug reactions or adverse events to health authorities or drug manufacturers for compilation, analysis, and effective action. This chapter describes some basic features of pharmacovigilance systems around the world.",
keywords = "Case report, Case series, Data mining, Database, Pharmacovigilance, Postmarketing drug safety, Reporting ratio, Signal detection, Spontaneous report, Surveillance",
author = "{Dal Pan}, {Gerald J.} and Marie Lindquist and Kate Gelperin",
year = "2012",
month = "1",
day = "3",
doi = "10.1002/9781119959946.ch10",
language = "English (US)",
isbn = "0470654759",
pages = "135--157",
booktitle = "Pharmacoepidemiology, Fifth Edition",
publisher = "Wiley-Blackwell",

}

TY - CHAP

T1 - Postmarketing Spontaneous Pharmacovigilance Reporting Systems

AU - Dal Pan, Gerald J.

AU - Lindquist, Marie

AU - Gelperin, Kate

PY - 2012/1/3

Y1 - 2012/1/3

N2 - Only 50 years ago the thalidomide tragedy served as a wake-up call to clinicians and health authorities worldwide and showed the need for effective systems to detect and seek to prevent such unforeseen consequences of therapeutic drug use. Today, increasingly sophisticated methods are employed in this effort, often referred to as pharmacovigilance. Much more needs to be done. Individuals are encouraged to report suspected adverse drug reactions or adverse events to health authorities or drug manufacturers for compilation, analysis, and effective action. This chapter describes some basic features of pharmacovigilance systems around the world.

AB - Only 50 years ago the thalidomide tragedy served as a wake-up call to clinicians and health authorities worldwide and showed the need for effective systems to detect and seek to prevent such unforeseen consequences of therapeutic drug use. Today, increasingly sophisticated methods are employed in this effort, often referred to as pharmacovigilance. Much more needs to be done. Individuals are encouraged to report suspected adverse drug reactions or adverse events to health authorities or drug manufacturers for compilation, analysis, and effective action. This chapter describes some basic features of pharmacovigilance systems around the world.

KW - Case report

KW - Case series

KW - Data mining

KW - Database

KW - Pharmacovigilance

KW - Postmarketing drug safety

KW - Reporting ratio

KW - Signal detection

KW - Spontaneous report

KW - Surveillance

UR - http://www.scopus.com/inward/record.url?scp=84888723920&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84888723920&partnerID=8YFLogxK

U2 - 10.1002/9781119959946.ch10

DO - 10.1002/9781119959946.ch10

M3 - Chapter

AN - SCOPUS:84888723920

SN - 0470654759

SN - 9780470654750

SP - 135

EP - 157

BT - Pharmacoepidemiology, Fifth Edition

PB - Wiley-Blackwell

ER -